作者
David Forman, Catherine de Martel, Charles J Lacey, Isabelle Soerjomataram, Joannie Lortet-Tieulent, Laia Bruni, Jerome Vignat, Jacques Ferlay, Freddie Bray, Martyn Plummer, Silvia Franceschi
发表日期
2012/11/20
来源
Vaccine
卷号
30
页码范围
F12-F23
出版商
Elsevier
简介
The worldwide prevalence of infection with human papillomavirus (HPV) in women without cervical abnormalities is 11–12% with higher rates in sub-Saharan Africa (24%), Eastern Europe (21%) and Latin America (16%). The two most prevalent types are HPV16 (3.2%) and HPV18 (1.4%). Prevalence increases in women with cervical pathology in proportion to the severity of the lesion reaching around 90% in women with grade 3 cervical intraepithelial neoplasia and invasive cancer. HPV infection has been identified as a definite human carcinogen for six types of cancer: cervix, penis, vulva, vagina, anus and oropharynx (including the base of the tongue and tonsils). Estimates of the incidence of these cancers for 2008 due to HPV infection have been calculated globally. Of the estimated 12.7 million cancers occurring in 2008, 610,000 (Population Attributable Fraction [PAF]=4.8%) could be attributed to HPV …
引用总数
2013201420152016201720182019202020212022202320244814719123822721721019114715714091
学术搜索中的文章